A novel presenilin 1 mutation, insR352, associated with a frontal temporal dementia phenotype has been identified (E. A. Rogaeva et al., 2001, Neurology 57, 621-625). This mutation does not increase A␤42 levels, but instead acts as dominant negative presenilin, decreasing amyloid ␤ protein (A␤) production by inhibiting ␥-secretase cleavage of the A␤ precursor. The distinct clinical phenotype associated with this mutation suggests that chronic partial inhibition of ␥-secretase activity may result in neurodegeneration.
INTRODUCTION
Presenilins (PSs) are evolutionarily conserved, homologous, membrane proteins that participate in the ␥-secretase cleavage that releases the amyloid ␤ protein (A␤) from the A␤ precursor (APP) (Golde & Younkin, 2001) . Presenilin 1 (PS1) and presenilin 2 mutations account for the majority of genetic forms of early onset familial Alzheimer disease (FAD). These mutations increase the production of A␤42, the more pathogenic form of A␤ (Hardy, 1997). Recently, it has been shown that dominant negative PS1 proteins can be generated by mutation of either of two conserved aspartate (D257, D385) residues or deletion of amino acids 81-154 (delTM1-2) (Murphy et al., 2000; Wolfe et al., 1999) . These mutations appear to inhibit ␥-secretase cleavage by decreasing the levels of functional endogenous PS in the active ␥-secretase complex. Here we describe a naturally occurring PS1 mutation, insR352, that, in contrast to other characterized FADlinked presenilin mutations, acts as a dominant negative PS markedly decreasing ␥-secretase cleavage of both APP and Notch.
METHODS

Mutation Analysis
The insR352 mutant was detected by PCR amplification followed by digestion of the product with a restriction enzyme. As the mutation failed to alter an enzyme recognition site, the PCR was performed using a mismatch forward primer in order to create an artificial diagnostic restriction site that could be used for mutation detection. An amplified fragment of 199 bp was generated using the primers CAGT-CATCTAGGGCCTCAAC (sense, mismatch) and GAATTAGACTGTAACACTCTC (antisense) and di-
